How SmartSignals Supplies Cut Annual Budgets for AstraZeneca & MedImmune Date Published: Apr 09, 2020 Case Study AstraZeneca & MedImmune chose Signant’s Forecasting, a web-enabled solution, to effectively forecast clinical supplies requirements and aggregate all supply and demand data into one convenient system. Although traditionally managed with independent projects or inefficient spreadsheets, clinical supply forecasting can cut costs and accelerate study startup times when in a digital format. When you choose Signant for your forecasting needs, your team will gain a live view of the supply position in each clinical trial. Learn more about the Forecasting solution and how it works. To access this resource, please fill out the fields below: Share: LinkedInTweet Recommended Resources Article Patient-Enhanced Drug Discovery and Development This PharmaVoice article argues that patients should be viewed as partners in drug development. While big pharma companies are incorporating... Read More Article Conversation with Bill Byrom & Mariana Fontana: Measuring Aspects of Health in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Marianna Fontana, Professor... Download Now Article Conversation with Bill Byrom & Julian Gillmore: Increasing the Usefulness of COAs in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Julian Gillmore, Professor... Download Now